| P2093 | author name string | Ting Shi | |
| | Dianne M Perez | |
| | Robert S Papay | |
| P2860 | cites work | Pharmacological and ischemic preconditioning of the human myocardium: mitoK(ATP) channels are upstream and p38MAPK is downstream of PKC | Q24798466 |
| | The cardiac mitochondrion: nexus of stress | Q28272979 |
| | A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V | Q28294206 |
| | The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse | Q28510005 |
| | Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4 | Q28580853 |
| | HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte | Q29620367 |
| | Inhibition of protein phosphatase 1 induces apoptosis in neonatal rat cardiac myocytes: role of adrenergic receptor stimulation | Q30657924 |
| | Essential activation of PKC-delta in opioid-initiated cardioprotection | Q31941069 |
| | Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes | Q33178140 |
| | Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes | Q33181618 |
| | Cellular stress responses: cell survival and cell death | Q33674213 |
| | Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. | Q33944297 |
| | Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway | Q34142604 |
| | Glucose transport and apoptosis | Q34170605 |
| | Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? | Q34207237 |
| | Hypoxia and glucose independently regulate the beta-adrenergic receptor-adenylate cyclase system in cardiac myocytes | Q34225541 |
| | An increase in the redox state during reperfusion contributes to the cardioprotective effect of GIK solution | Q34337997 |
| | Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload | Q34498911 |
| | Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure | Q36286936 |
| | Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation | Q36438849 |
| | α(1A)-adrenergic receptor differentially regulates STAT3 phosphorylation through PKCϵ and PKCδ in myocytes | Q36761033 |
| | Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury | Q36852069 |
| | Mitochondrial protein kinase Cepsilon (PKCepsilon): emerging role in cardiac protection from ischaemic damage | Q36979574 |
| | Hexokinase-mitochondrial interactions regulate glucose metabolism differentially in adult and neonatal cardiac myocytes | Q37209189 |
| | New insights into myocardial glucose metabolism: surviving under stress | Q37507460 |
| | Bioenergetics of the failing heart | Q37792507 |
| | Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. | Q37831555 |
| | Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes | Q37845379 |
| | alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes | Q40941082 |
| | Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions | Q41592350 |
| | Translocation of the brain-type glucose transporter largely accounts for insulin stimulation of glucose transport in BC3H-1 myocytes | Q41726185 |
| | Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. | Q42161174 |
| | Overexpression of alpha1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy | Q42461428 |
| | ??? | Q64764692 |
| | A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. | Q42849642 |
| | Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor | Q43559440 |
| | Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy | Q43709982 |
| | Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy | Q43932226 |
| | Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes | Q44051395 |
| | Characteristics of death of neonatal rat cardiomyocytes following hypoxia or hypoxia-reoxygenation: the association of apoptosis and cell membrane disintegrity | Q44181162 |
| | Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator | Q44513177 |
| | Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes | Q44543591 |
| | Delayed myocardial preconditioning by alpha1-adrenoceptors involves inhibition of apoptosis | Q44860124 |
| | Loss of PKC-delta alters cardiac metabolism | Q44995355 |
| | Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice | Q44995360 |
| | Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction. | Q45135938 |
| | alpha1A- but not alpha1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism | Q45216536 |
| | Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts | Q45731326 |
| | Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial | Q46504683 |
| | Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin | Q46861458 |
| | Adrenergic induction of bimodal myocardial protection: signal transduction and cardiac gene reprogramming. | Q51461021 |
| | Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. | Q54591200 |
| | An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes | Q64377257 |
| | Comparative effects of hypoxia and ischemia in the isolated, blood-perfused dog heart: evaluation of left ventricular diastolic chamber distensibility and wall thickness | Q69934322 |
| | Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism | Q70474449 |
| | Alpha 1-adrenergic stimulation induces cardiac tolerance to hypoxia via induction and activation of Mn-SOD | Q71738201 |
| | Preconditioning of isolated rat heart is mediated by protein kinase C | Q71988463 |
| | Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart | Q72312512 |
| | alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C | Q72688569 |
| | Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts | Q74332431 |
| | "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with In situ nick end-labeling | Q77369169 |
| | Activation of alpha1-adrenergic receptor during Ca2+ pre-conditioning elicits strong protection against Ca2+ overload injury via protein kinase C signaling pathway | Q77926995 |
| | Glucose for the heart | Q77932890 |
| | The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes | Q78208404 |
| | A routine method for the estimation of lactic dehydrogenase activity | Q78795693 |
| | Nicotinamide pretreatment protects cardiomyocytes against hypoxia-induced cell death by improving mitochondrial stress | Q84379438 |
| | Phenylephrine preconditioning involves modulation of cardiac sarcolemmal K(ATP) current by PKC delta, AMPK and p38 MAPK | Q84527251 |
| P433 | issue | 3 | |
| P304 | page(s) | 261-270 | |
| P577 | publication date | 2015-09-29 | |
| P1433 | published in | Journal of Receptors and Signal Transduction | Q6295837 |
| P1476 | title | α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake | |
| P478 | volume | 36 | |